Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1795198 Target Snapshot

STE20-related kinase adapter protein alpha · SINGLE PROTEIN · Homo sapiens

269Compounds
41Assays
1Approved Drugs
240.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q7RTN6. Use UniProt Q7RTN6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q7RTN6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats STE20-related kinase adapter protein alpha as ChEMBL target CHEMBL1795198, mapped to UniProt Q7RTN6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
STE20-related kinase adapter protein alpha
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1795198
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q7RTN6
STE20-related kinase adapter protein alpha
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether STE20-related kinase adapter protein alpha is the right protein anchor across sources, using UniProt Q7RTN6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSTE20-related kinase adapter protein alpha
UniProt AccessionQ7RTN6
Component TypeProtein
Sequence Length431 aa

STE20-related kinase adapter protein alpha

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as STE20-related kinase adapter protein alpha, mapped to UniProt Q7RTN6. Sequence length is 431 aa.

Mapped IDQ7RTN6
Review nameSTE20-related kinase adapter protein alpha
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
2
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC503.0
KD237.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3752910 7.7 Kd 19.76 Preclinical
CHEMBL1231124 6.5 Kd 316.0 Clinical
CHEMBL1088751 6.17 Kd 672.0 Clinical
CHEMBL4088216 6.0 IC50 1000.0 Preclinical
CHEMBL4097778 6.0 IC50 1000.0 Preclinical
CHEMBL4549667 6.0 IC50 1000.0 Preclinical
CHEMBL377300 5.94 Kd 1137.0 Clinical
CHEMBL296468 5.55 Kd 2807.0 Preclinical
CHEMBL1789941 5.43 Kd 3672.0 Approved
Distribution

pChEMBL Value Distribution

1
5.0
2
5.5
4
6.0
1
6.5
0
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

41
Total Assays
9
Tested Compounds
1
Assay Types
Binding — 41 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
subcellular format 18 5 5.9
cell-based format 14 0
single protein format 9 4 6.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine